John Wayne Cancer Institute (JWCI)
Santa Monica, California 90404
1 studies enrolling now · 2 studies all time
What they study most
Clear Cell Renal Cell Carcinoma (ccRCC), Melanoma, Metastatic Castration-Resistant Prostate Cancer (mCRPC)
Studies at this site
- A Trial to Find Out if REGN5678 (Nezastomig) is Safe and How Well it Works Alone or in Combination With Cemiplimab for Adult Participants With Metastatic Castration-Resistant Prostate Cancer and Other Tumors — Recruiting now
- A Trial to See if the Combination of Fianlimab With Cemiplimab Works Better Than Pembrolizumab for Preventing or Delaying Melanoma From Coming Back After it Has Been Removed With Surgery — Running, not enrolling